Cathie Wood Just Bet $46 Million on a Newly Public AI Chip Stock. Should You Follow Her?
By Maksym Misichenko · Nasdaq ·
By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on Cerebras, citing high valuation, heavy reliance on a few customers, and significant execution risks in the cloud pivot, particularly around capex intensity, margin compression, and potential geopolitical risks.
Risk: Heavy capex intensity and potential underutilization of data center capacity leading to margin compression and cash burn.
Opportunity: Potential for significant revenue growth if wafer-scale manufacturing yields can be scaled without catastrophic margin compression.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Cerebras Systems went public on May 14, raising more than $6 billion in the biggest tech IPO of the year.
The chipmaker's customer roster now includes OpenAI, which signed a multi-year compute deal worth more than $20 billion.
Even after a pullback, shares trade at more than 120 times sales.
ARK Investment Management came out swinging last week, scooping up shares of one of the year's most hyped artificial intelligence (AI) initial public offerings. According to its trading disclosures published Friday, Cathie Wood's firm bought 149,176 shares of newly public Cerebras Systems (NASDAQ: CBRS) for roughly $46.4 million through its ARK Innovation and ARK Next Generation Internet exchange-traded funds. That came on top of a smaller purchase the day before.
The buying followed one of the year's most closely watched Nasdaq debuts. After pricing its initial public offering (IPO) at $185 per share -- well above an initial range of $115 to $125 -- the wafer-scale chip company opened at $350 on May 14 and closed its first day at $311.07 -- a gain of 68%. Demand for the offering reportedly came in at more than 20 times the available supply, making it the largest U.S. tech IPO so far in 2026.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
So, should retail investors follow Wood here and similarly buy shares of this hot AI company? After all, Cerebras' technology and customer wins are genuinely impressive. But once you look at the price tag investors are now being asked to pay, things start to look a little uncomfortable.
Cerebras isn't trying to build a slightly cheaper version of an Nvidia graphics processing unit (GPU). Its pitch is architectural. The Sunnyvale, California-based company's Wafer-Scale Engine 3 takes up an entire silicon wafer rather than being diced into smaller chips -- about 57 times larger than today's largest GPU. That single piece of silicon packs 4 trillion transistors, 900,000 AI cores, and 44 gigabytes of on-chip memory, which the company says can deliver AI inference up to 15 times faster than leading GPU-based systems.
The financial picture is improving quickly, too. Revenue rose 76% in 2025 to $510 million -- up from $290 million in 2024, according to the company's prospectus. Cerebras also swung to a net profit of $238 million after losing nearly $482 million the year before.
The customer roster has expanded as well. In January, Cerebras signed a multi-year compute agreement with OpenAI valued at more than $20 billion, under which OpenAI will deploy 750 megawatts of Cerebras compute capacity through 2028. OpenAI also extended a $1 billion working capital loan to help fund the buildout. Then, in March, Amazon signed a binding term sheet, making AWS the first hyperscaler to deploy Cerebras systems in its data centers, with the solution made available through Bedrock.
"OpenAI and Cerebras have agreed to co-design future models for future Cerebras hardware," wrote Cerebras CEO Andrew Feldman in the founders' letter included in the company's IPO prospectus.
It's a credible challenge to Nvidia's near-total dominance in AI accelerators -- and probably the best reason to take ARK's enthusiasm seriously.
But excitement about the technology doesn't justify what investors are now paying for the stock. As of this writing, shares trade near $300, putting the company's market capitalization north of $63 billion. That works out to more than 120 times trailing-12-month sales. And, using last year's earnings, the price-to-earnings ratio sits near 700.
For context, Nvidia trades at about 45 times earnings while generating more than $215 billion in trailing revenue and growing in excess of 60% year over year.
Then there's the customer concentration issue. Two UAE-affiliated entities -- the Mohamed bin Zayed University of Artificial Intelligence and G42 -- together accounted for about 86% of Cerebras' 2025 revenue, with MBZUAI alone responsible for 62%. And, going forward, OpenAI is expected to make up a substantial chunk of revenue itself. Concentration like that can be a tailwind when those customers are spending freely. But one paused contract, one budget shift, or one change in U.S. export rules could reshape the income statement in a hurry.
Investors should also note that Cerebras is increasingly operating as an AI cloud provider -- not just a chip vendor. Under the OpenAI agreement, Cerebras is building or leasing data centers, installing its own systems, and running them as a service. That model carries heavier capital requirements and execution risk than simply shipping hardware.
Cerebras -- the business -- may well be a long-term winner in AI infrastructure. But at a price near 125 times sales and 700 times earnings, the stock pretty much leaves no room for anything to go wrong. Wood's funds are built around concentrated bets on disruptive technology -- and small positions in moonshots like this fit her mandate. For most individual investors, though, the better move is probably to watch this one from the sidelines until the stock's valuation comes down meaningfully.
Before you buy stock in Cerebras Systems, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Cerebras Systems wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $483,476! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,362,941!
Now, it’s worth noting Stock Advisor’s total average return is 998% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 19, 2026. *
Daniel Sparks and his clients have no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon and Nvidia. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Cerebras' move into capital-intensive cloud services creates downside risk at current multiples that the article understates."
Cerebras' wafer-scale architecture and OpenAI's $20B multi-year deal signal real technical differentiation from Nvidia GPUs, yet the article downplays the shift to operating as an AI cloud provider. This model requires massive data-center capex and ongoing maintenance that chip-only peers avoid, likely pressuring free cash flow even as revenue scales. At 120x trailing sales and 700x earnings with 86% revenue tied to two UAE entities plus OpenAI, any delay in Bedrock deployments or export curbs on Middle East contracts would trigger sharp re-rating. ARK's $46M purchase fits its high-conviction style but leaves little margin for execution slippage in 2026-2028 buildouts.
The $20B OpenAI commitment plus Amazon Bedrock availability could drive 50%+ margins once utilization hits scale, making 120x sales look cheap if Cerebras captures even 5% of inference spend.
"Cerebras' shift from hardware vendor to capital-intensive cloud operator, combined with 86% customer concentration and 700x trailing P/E, leaves zero margin for error on execution, customer retention, or geopolitical headwinds."
Cerebras has genuine architectural merit—wafer-scale design, 15x inference speed claims, and OpenAI's $20B deal are real. But the article undersells the execution risk. Cerebras is pivoting from chip vendor to cloud operator, which means capex intensity, margin compression, and operational complexity the market hasn't priced in. At 125x sales with 62% revenue from one customer (MBZUAI), the stock prices in flawless execution, zero geopolitical friction on UAE deals, and OpenAI not diversifying suppliers. Wood's $46M bet is portfolio-sized for ARK; retail investors are being sold the sizzle of 'Nvidia killer' without the substance of unit economics or path to profitability at scale.
If OpenAI's $20B commitment is binding and Cerebras delivers the promised 15x speedup, this could be a genuine infrastructure winner where early-stage valuation compression is temporary—similar to how Nvidia looked expensive in 2016 before the AI boom.
"Cerebras' transition to a cloud-service model introduces capital-intensive risks that are currently being masked by aggressive growth multiples and extreme customer concentration."
Cerebras is being priced as a software-margin monopoly, but it is fundamentally a capital-intensive infrastructure play. Trading at 120x sales, the market is ignoring the massive 'CapEx drag' inherent in their cloud-provider pivot. While the OpenAI deal provides a $20 billion revenue horizon, it also creates a dangerous dependency on a single customer's roadmap and capital solvency. ARK’s entry is classic momentum chasing disguised as disruptive innovation. Unless Cerebras proves it can scale wafer-scale manufacturing yields without catastrophic margin compression, this valuation is untethered from reality. I expect a significant re-rating once the initial lock-up period expires and the reality of hardware-as-a-service depreciation hits the balance sheet.
If Cerebras' wafer-scale architecture achieves a genuine 'compute-per-watt' breakthrough that renders standard GPU clusters obsolete, the current premium is actually a bargain compared to the total addressable market of AI training.
"The current valuation already embeds an outsized, unlikely-to-be-sustained growth path; without broad-based revenue diversification beyond a few big customers, the upside is highly contingent and vulnerable to multiple compressions."
Cerebras' Wafer-Scale Engine 3 plus OpenAI/AWS traction signals real AI infra potential, but the stock is pricing in perfection. With a $63B+ market cap on 2025 revenue of $510M, the multiple is ~120x sales and ~700x earnings, leaving little room for missteps. Concentration is extreme: MBZUAI ~62% of 2025 revenue and UAE affiliates ~86% combined. The OpenAI deal is meaningful but not guaranteed to scale smoothly; regulatory/export changes could hit income. The shift toward cloud provisioning brings heavy capex (data centers, 750 MW capacity through 2028), elevating execution risk. Without broad, durable demand, upside depends on an unlikely, sustained revenue surge across multiple customers.
Bearish case: even large, long-duration contracts can be paused or renegotiated; a shift in OpenAI's strategy or stricter export rules could abruptly cut revenue, and the massive capex burden to operate as a cloud provider may erode margin and liquidity.
"Export curbs could strand planned data-center capacity and accelerate losses beyond current valuation assumptions."
Claude correctly flags execution risks in the cloud pivot, but both he and Gemini overlook how export curbs on UAE contracts—already 86% of revenue—could strand the 750 MW capacity buildout before utilization hits scale. This directly amplifies Grok's free cash flow pressure, turning planned 2027-2028 infrastructure into depreciating liabilities rather than margin drivers if OpenAI diversifies suppliers.
"Export restrictions matter less than the capex trap: stranded infrastructure at low utilization kills cash flow faster than revenue loss alone."
Grok's export-curb scenario is real, but it assumes OpenAI won't hedge geopolitical risk by diversifying compute suppliers—which is exactly what a $20B customer would do. The deeper issue: even if UAE revenue survives, Cerebras' margin story collapses if they're forced to operate 750 MW of underutilized capacity. Nobody's quantified the cash burn if utilization drops below 60%. That's the actual cliff, not just customer concentration.
"The OpenAI deal functions as a strategic hedge on architecture, making the hardware yield the primary failure point rather than mere cloud utilization."
Claude, you’re missing the 'lock-in' dynamic. OpenAI isn't just diversifying suppliers; they are betting on a specialized architecture to bypass the H100/B200 bottleneck. If Cerebras’ wafer-scale engine delivers the promised 15x inference speed, OpenAI’s $20B commitment acts as a defensive moat, not just a service contract. The real risk isn't just utilization; it's the yield-on-wafer. If they can't scale manufacturing, the cloud pivot fails regardless of demand. We are betting on physics, not just software.
"Wafer-scale manufacturing yield and the related operating costs are the real margin risks, not merely capacity utilization."
Claude raises a real margin-risk red flag from 750 MW of underutilized capacity, but the bigger truth is hardware-as-a-service economics. Even with a promised 15x speedup, poor utilization plus heavy depreciation could erode cash flow for years, especially if export curbs bite and OpenAI hedges supply. The core risk is wafer-scale manufacturing yield and the related Opex, not just capacity; without clear margin accretion, 120x sales looks fragile.
The panel consensus is bearish on Cerebras, citing high valuation, heavy reliance on a few customers, and significant execution risks in the cloud pivot, particularly around capex intensity, margin compression, and potential geopolitical risks.
Potential for significant revenue growth if wafer-scale manufacturing yields can be scaled without catastrophic margin compression.
Heavy capex intensity and potential underutilization of data center capacity leading to margin compression and cash burn.